Brief: Abionyx Announces Recruitment Of Last Patient In Phase 2A Clinical Trial With CER-001

Abionyx Pharma SA

04/10/2022 17:05

Oct 4 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX ANNOUNCES THE RECRUITMENT OF THE LAST PATIENT IN
THE
PHASE 2A CLINICAL TRIAL WITH CER-001
    * THE COMPANY RECONFIRMS THAT FINAL KEY RESULTS WILL BE
RELEASED
BY LATE FALL OF 2022

Further company coverage:  ABNX.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))